Company / Free Cash Flow
Lipocine Inc. Free Cash Flow History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$1.3M
FY2025
5-year range
-$15.3M / -$1.3M
FY2021-FY2025
Trend
+89.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has fluctuated over the past 7 years, ranging from -$18M in FY2018 to -$1M in FY2025.
Based on SEC 10-K filings.
-$1M in FY2025.
Improved from -$12M to -$1M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 89.0% year-over-year.
- Lowest free cash flow in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.16 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.3M | +89.0% |
| FY2024 | -$11.9M | +1.8% |
| FY2023 | -$12.1M | -173.9% |
| FY2022 | -$4.4M | +71.1% |
| FY2021 | -$15.3M | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | -$18.3M | -474.8% |
| FY2013 | -$3.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026